Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) ...

Smith & Nephew has announced it has revised plans to leave Hull after almost 170 years in the city, citing an increase in ...

Smith+Nephew (NYSE: SNN) announced today that it launched its Legion hinged knee (HK) system with Oxinium implant technology ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System.

Local leaders have expressed their delight at the company's revised plan to keep its Hull site open and build a new facility ...

The GENESIS II Total Knee System has grown to become one of the most trusted total knee systems on the market. Cutting edge instrumentation, such as the user friendly MIS system and the ream-thru ...

Smith & Nephew (LSE:SN.) is navigating a dynamic period marked by both opportunities and challenges. Recent highlights include a notable 31.2% increase in dividend payouts and innovative product ...

The medical company announced in 2022 that it was leaving the city but now says it plans to operate in both Hull and Melton ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) System is now available in the United States with proprietary OXINIUM ...

Smith & Nephew has announced it has revised plans to leave Hull after almost 170 years in the city, citing an increase in costs for the decision. In 2022, the global medical company announced it ...

Smith & Nephew (LSE:SN.) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) System is now available in the United States with proprietary OXINIUM (Oxidized ...